Presentation Cardiovascular Interventions 2018 Show me the Data: Key Clinical Trials of 2018 Presenter: Ehtisham Mahmud October 26, 2018
Presentation JIM 2017 Perspectives on the ABSORB Randomized Trials: Take-home Messages for the Clinical Practitioner Presenter: Gregg W. Stone February 08, 2017
Presentation TCT 2016 NOBLE: A Prospective, Randomized Trial Comparing Biolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease Presenter: Martin B. Leon, Keith G. Oldroyd, Evald H. Christiansen October 31, 2016
Presentation TCT 2016 EXCEL: A Prospective, Randomized Trial Comparing Everolimus-Eluting Stents and Bypass Graft Surgery in Selected Patients With Left Main Coronary Artery Disease Presenter: Martin B. Leon, Keith G. Oldroyd, Gregg W. Stone October 31, 2016
Presentation TCT 2016 BIONICS: A Prospective, Randomized Trial of a Ridaforolimus-Eluting Coronary Stent vs a Zotarolimus-Eluting Stent in a More-Comers Population of Patients With Coronary Artery Disease Presenter: Gregg W. Stone, Wayne B. Batchelor, David E. Kandzari October 30, 2016
Presentation TCT 2016 BIO-RESORT (TWENTE III): A Prospective, Randomized Three-Arm Trial Comparing Two Different Biodegradable Polymer-Based Drug-Eluting Stents and a Durable Polymer-Based Drug-Eluting Stent in an All-Comers Population of Patients With Coronary Artery Disease Presenter: Gregg W. Stone, Wayne B. Batchelor, Clemens von Birgelen October 30, 2016
Presentation TCT 2015 Late Breaking Trials: LEADERS FREE and RESPECT LATE Presenter: Gregg W. Stone November 23, 2015
Presentation ISET 2015 Update on Peripheral Artery Stent Surveillance: Have We Learned Anything from Clinical Trials? Presenter: Michael R. Jaff January 31, 2015
Presentation TCT 2014 Three Year Clinical Outcomes of a Unique Sirolimus-Eluting Stent with Fully Absorbable Polymer Coating: Long-term Results from the DESSOLVE I and the DESSOLVE II Clinical Trials_ Presenter: John Ormiston September 16, 2014
Presentation TCT 2014 RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents Presenter: Gregg W. Stone, Pieter C. Smits, Fernando Alfonso September 14, 2014
Presentation TCT 2014 ABSORB II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease Presenter: Gregg W. Stone, Pieter C. Smits, Patrick W. Serruys September 14, 2014
Presentation TCT 2013 Yes – There are No Substantial Clinical Trials Proving Safety or Efficacy! Presenter: Sigmund Silber October 31, 2013
Presentation TCT 2013 Synthesis of the ISAR Clinical Trials Comparing Different Stents in Different Settings Presenter: Adnan Kastrati October 28, 2013
Presentation TCT 2013 Synthesis of Clinical Trials with the Nobori Stent Presenter: Takeshi Kimura October 28, 2013
Presentation TCT 2013 Synthesis of Clinical Trials with the Biomatrix Stent Presenter: Stephan Windecker October 28, 2013
Presentation TCT 2013 Insights from the TWENTE Series of Clinical Trials: Past, Present, and Future Presenter: Clemens von Birgelen October 28, 2013
Presentation TCT 2013 Insights from the SORT-OUT Series of Clinical Trials: Past, Present, and Future Presenter: Lisette Okkels Jensen October 28, 2013
Presentation TCT 2013 Insights from the COMPARE Series of Clinical Trials: Past, Present, and Future Presenter: Peter Smits October 28, 2013
Presentation TCT 2013 Yes: Clinical Trials Wwll Show Fewer Early and Late Events! Presenter: Didier Carri? October 27, 2013
Presentation TCT 2013 The BioMime Stent and Merit Clinical Trials Presenter: Martin Leon October 27, 2013